Wells Fargo’s NextCure NXTC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,157
| Closed | -$4.81K | – | 6829 |
|
2024
Q1 | $4.81K | Buy |
2,157
+2,002
| +1,292% | +$4.46K | ﹤0.01% | 5504 |
|
2023
Q4 | $177 | Buy |
155
+9
| +6% | +$10 | ﹤0.01% | 6197 |
|
2023
Q3 | $188 | Buy |
146
+16
| +12% | +$21 | ﹤0.01% | 6226 |
|
2023
Q2 | $234 | Buy |
130
+5
| +4% | +$9 | ﹤0.01% | 6347 |
|
2023
Q1 | $185 | Buy |
125
+2
| +2% | +$3 | ﹤0.01% | 6472 |
|
2022
Q4 | $173 | Buy |
123
+3
| +3% | +$4 | ﹤0.01% | 6332 |
|
2022
Q3 | $0 | Buy |
120
+1
| +0.8% | – | ﹤0.01% | 6812 |
|
2022
Q2 | $1K | Buy |
+119
| New | +$1K | ﹤0.01% | 6260 |
|
2022
Q1 | – | Sell |
-25
| Closed | – | – | 7060 |
|
2021
Q4 | $0 | Sell |
25
-1,570
| -98% | – | ﹤0.01% | 7044 |
|
2021
Q3 | $11K | Sell |
1,595
-15,713
| -91% | -$108K | ﹤0.01% | 5848 |
|
2021
Q2 | $138K | Sell |
17,308
-2,651
| -13% | -$21.1K | ﹤0.01% | 4864 |
|
2021
Q1 | $199K | Sell |
19,959
-27,596
| -58% | -$275K | ﹤0.01% | 4834 |
|
2020
Q4 | $518K | Sell |
47,555
-11,642
| -20% | -$127K | ﹤0.01% | 4408 |
|
2020
Q3 | $521K | Buy |
59,197
+2,945
| +5% | +$25.9K | ﹤0.01% | 4200 |
|
2020
Q2 | $1.21M | Buy |
56,252
+42,902
| +321% | +$920K | ﹤0.01% | 3588 |
|
2020
Q1 | $495K | Buy |
13,350
+3,193
| +31% | +$118K | ﹤0.01% | 3926 |
|
2019
Q4 | $572K | Buy |
10,157
+8,700
| +597% | +$490K | ﹤0.01% | 4167 |
|
2019
Q3 | $45K | Buy |
1,457
+1,436
| +6,838% | +$44.4K | ﹤0.01% | 5290 |
|
2019
Q2 | $0 | Buy |
+21
| New | – | ﹤0.01% | 6082 |
|